Search by Drug Name or NDC
NDC 24208-0398-30 Ipratropium bromide 21 ug/1 Details
Ipratropium bromide 21 ug/1
Ipratropium bromide is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is IPRATROPIUM BROMIDE.
MedlinePlus Drug Summary
Ipratropium nasal spray is available in two strengths that are used to treat different conditions. Ipratropium nasal spray 0.06% is used to relieve a runny nose caused by the common cold or seasonal allergies (hay fever) in adults and children age 5 and older. Ipratropium nasal spray 0.03% is used to relieve a runny nose caused by year-round allergic and nonallergic rhinitis (runny nose and stuffiness) in adults and children age 6 and older. Ipratropium nasal spray does not relieve nasal congestion, sneezing, or postnasal drip caused by these conditions. Ipratropium nasal spray is in a class of medications called anticholinergics. It works by reducing the amount of mucus produced in the nose.
Related Packages: 24208-0398-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ipratropium Nasal Spray
Product Information
| NDC | 24208-0398 |
|---|---|
| Product ID | 24208-398_a2b4ae27-595c-4938-a93a-715339b7eab7 |
| Associated GPIs | 42300040102010 |
| GCN Sequence Number | 024457 |
| GCN Sequence Number Description | ipratropium bromide SPRAY 21 MCG NASAL |
| HIC3 | Q7A |
| HIC3 Description | NOSE PREPARATIONS, MISCELLANEOUS (RX) |
| GCN | 42239 |
| HICL Sequence Number | 000057 |
| HICL Sequence Number Description | IPRATROPIUM BROMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Ipratropium bromide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ipratropium bromide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, METERED |
| Route | NASAL |
| Active Ingredient Strength | 21 |
| Active Ingredient Units | ug/1 |
| Substance Name | IPRATROPIUM BROMIDE |
| Labeler Name | Bausch & Lomb Incorporated |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076025 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 24208-0398-30 (24208039830)
| NDC Package Code | 24208-398-30 |
|---|---|
| Billing NDC | 24208039830 |
| Package | 1 BOTTLE, SPRAY in 1 CARTON (24208-398-30) / 345 SPRAY, METERED in 1 BOTTLE, SPRAY |
| Marketing Start Date | 2003-03-31 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.70125 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | IPRATROPIUM 0.03% SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |